CHU Bordeaux — Pessac

Public research footprint of CHU Bordeaux, compiled from the ClinicalTrials.gov public registry.

235

Registered studies

104

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Metastatic Non-small Cell Lung Cancer With MTAP Deletion · Untreated, Unresectable, or Metastatic Colorectal Cancer · Diffuse Large B-cell Lymphoma

Recently updated registry entries

NCT05159492 — Ground-Breaking Electroporation-based Intervention for PAROXysmal Atrial Fibrillation… (Completed)
NCT07218029 — A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension… (Recruiting)
NCT06077760 — A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Bordeaux?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.